Immunoassay of insulin-like growth factor binding protein-I

Clinical Chemistry

Volumn 43, Issue 3, 1997, Pages 523-532

  Khosravi, M Javad ^a,b,c   Diamandi, Anastasia ^a   Mistry, Jehangir ^a  

^a Diagnostic Systems Laboratories Inc   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

ELISA; insulin like growth factor binding proteins; insulin like growth factors; phosphorylation

Indexed keywords

ALKALINE PHOSPHATASE; SOMATOMEDIN BINDING PROTEIN 1;

AMNION FLUID; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE INTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; SYNOVIAL FLUID;

EID: 0031052736     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.3.523     Document Type: Article

References (33)

1. Rotwein P. Structure, evolution, expression and regulation of insulin-like growth factors I and II [Review]. Growth Factors 1991; 5:3-18.
2. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentration. Endocr Rev 1989;10:68-91.
3. LeRoith D, Adamo M, Werner H, Roberts CT Jr. Insulin-like growth factors and their receptors as growth regulators in normal physiology and pathological states [Review]. Trends Endocrinol Metab 1991;2:134-9.
4. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
5. Rosenfeld RG, Lamson G, Pham H, Oh Y, Conover C, De Leon DD, et al. Insulin-like growth factor-binding proteins [Review]. Recent Prog Horm Res 1990;46:99-163.
6. Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, 4, -5 and -6) [Review]. Prog Growth Factor Res 1991;1:243-66.
7. Lamson G, Giudice L, Rosenfeld R. Insulin-like growth factor binding proteins: structural and molecular relationships [Review]. Growth Factors 1991;5:19-28.
8. Holly JMP, Martin JI. IGFBPs: a review of methodological aspects of their purification, analysis and regulation [Review]. Growth Regul 1994;4(Suppl 1):20-30.
9. Cohen P, Rosenfeld RG. Physiologic and clinical relevance of the insulin-like growth factor binding proteins [Review]. Curr Opin Pediatr 1994;6:462-7.
10. Koistinen R, Kalkkinen N, Huhtala ML, Seppala M, Bonn H, Rutanen E-M. Placental protein 12 is a decidual protein that binds somatomedin and has an identical N-terminal amino acid sequence with somatomedin binding protein from human amniotic fluid. Endocrinology 1986;118:1375-8.
11. Bell SC, Keyte JW. N-terminal amino acid sequence of human pregnancy-associated endometrial alpha 1-globulin, an endometrial insulin-like growth factor (IGF) binding protein: evidence for two small molecular weight IGF binding proteins. Endocrinology 1988;123:1202-4.
12. Lee PDK, Conover CA, Powell DR. Regulation and function of insulin-like growth factor binding protein-1. Proc Soc Exp Biol Med 1993;204:4-29.
13. Powell DR, Suwanichkul A, Cubbage ML, DePaolis LA, Snuggs MB, Lee PDK. Insulin inhibits transcription of the human gene for insulin-like growth factor binding protein-1. J Biol Chem 1991; 266:18868-76.
14. Suikkari A-M, Jalkanen J, Koistinen R, Butzow R, Ritvos O, Ranta T, Seppala M. Human granulosa cells synthesize low molecular weight insulin-like growth factor-binding protein. Endocrinology 1989;124:1088-90.
15. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992;13:641-69.
16. Frost RA, Tseng L. Insulin-like growth factor binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. J Biol Chem 1991;266:18082-8.
17. Rutanen E-M, Bohn H, Seppala M. Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease. Am J Obstet Gynecol 1982;144:460-3.
18. Hills FA, Gunn LK, Hardiman P, Thamaratnam S, Chard T. IGFBP-1 in the placenta, membranes and fetal circulation: levels at term and preterm delivery. Early Hum Dev 1996;44:71-6.
19. Hills FA, English J, Chard T. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 1996;148:303-9.
20. Westwood M, Gibson JM, Williams AC, Clayton PE, Hamberg O, Flyvbjerg A, White A. Hormonal regulation of circulating insulin-like growth factor-binding protein-1 phosphorylation status. J Clin Endocrinol Metab 1995;80:3520-7.
21. Lewitt MS, Denyer GS, Conney GJ, Baxter RC. Insulin-like growth factor binding protein-1 modulates blood glucose levels. Endocrinology 1991;129:2254-6.
22. Liu L, Brinkman A, Blat C, Harel L. IGFBP-1, an insulin-like growth factor binding protein, is a cell growth inhibitor. Biochem Biophys Res Commun 1991;174:673-9.
23. Eglin RG, Busby WH, Clemmons DR. An insulin-like growth factor (IGF) binding protein enhances the biological response to IGF-I. Proc Natl Acad Sci U S A 1987;84:3254-8.
24. Busby WH, Hossenlopp P, Binoux M, Clemmons DR. Purified preparations of the amniotic fluid derived insulin-like growth factor binding protein contain multimeric forms that are biologically active. Endocrinology 1989;125:7481-5.
25. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci U S A 1991;88:7481-5.
26. Koistinen R, Angervo M, Leinonen P, Hakala T, Seppala M. Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy. Clin Chem Acta 1993;215:189-99.
27. Westwood M, Gibson JM, Davies AJ, Young RJ, White A. The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 1994;79: 1735-41.
28. Powell DR, Lee PDK, Shively JE, Eckenhausen M, Hintz RL. Method for purification of an insulin-like growth factor-binding protein produced by human HEP-G2 hepatoma cells. J Chromatogr B Biomed Appl 1987;420:163-70.
29. Khosravi MJ, Morton RC. Novel application of streptavidin-hapten derivative as protein-tracer conjugate in competitive-type immunoassays involving biotinylated detection probes. Clin Chem 1991; 37:58-63.
30. Khosravi MJ, Papanastasiou-Diamandi A, Mistry J. Ultrasensitive immunoassay for prostate-specific antigen based on conventional colorimetric detection. Clin Biochem 1995;28:407-14.
31. Khosravi MJ, Diamandis EP. Immunofluorometry of choriogonadotropin by time-resolved fluorescence spectroscopy, with a new europium chelate as label. Clin Chem 1987;33:1994-9.
32. Khosravi MJ, Diamandi A, Mistry J, Lee PDK. Noncompetitive ELISA for human serum insulin-like growth factor-I. Clin Chem 1996;42:1147-54.
33. Pekonen F, Karkkainen T, Tanner P, Webber T, Rutanen E-M. A monoclonal antibody-based immunometric assay for low molecular weight insulin-like growth factor binding protein/placental protein 12. J Immunoassay 1989;10:325-37.